How were Australian Pharmaceutical Industries' earnings last quarter?

Australian Pharmaceutical Industries Limited (ASX:API) issued its earnings results on Wednesday, April, 17th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.05 by $0.00.

Is Australian Pharmaceutical Industries a good dividend stock?

Australian Pharmaceutical Industries (ASX:API) pays an annual dividend of A$0.04 per share and currently has a dividend yield of 2.29%. The dividend payout ratio is 1,333.33%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for API .

What other stocks do shareholders of Australian Pharmaceutical Industries own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM) , Austal (ASB) , Mod Resources (MOD) , Harvey Norman (HVN) , Evolution Mining (EVN) and Downer EDI (DOW) .

ASX:API

Australian Pharmaceutical Industries (API) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free API Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 453,647 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 2.29%
Price Target: N/A

Stock Analysis

Get Australian Pharmaceutical Industries alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Australian Pharmaceutical Industries Stock (ASX:API)

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

API Stock News Headlines

March 29, 2024 | au.finance.yahoo.com

Chemist Warehouse speaks out over fears Sigma Healthcare merger will raise prices

March 28, 2024 | msn.com

African Pharmaceutical Technology Foundation and Pharmaceutical Institute Partner to Strengthen Nigeria's Pharmaceutical and Vaccine Manufacturing Capacity [announcement]

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 18, 2024 | sg.finance.yahoo.com

Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule

February 27, 2024 | msn.com

Real Housewives of Dubai's Caroline Stanbury and her soccer star husband Sergio Carrallo are left furious after booking the 'best seats on the plane' - only to find themselves ...

February 26, 2024 | dailymail.co.uk

Beyonce's uncle dead at 77: Megastar's mom Tina Knowles reveals Air Force veteran older brother Butch has passed away

February 23, 2024 | bizjournals.com

Local innovation nonprofit focused on drug manufacturing inks pact with key industry group

February 5, 2024 | finance.yahoo.com

Global Blister Packaging Market to Reach Value of USD 42.71 Billion by 2030 | Skyquest Technology

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

February 5, 2024 | sg.news.yahoo.com

India's Alembic Pharma beats Q3 profit view on strong domestic, US sales

January 16, 2024 | msn.com

Continuous Flow Chemistry for Scalable Drug Synthesis

January 6, 2024 | nasdaq.com

February 23rd Options Now Available For Teva Pharmaceutical Industries

December 15, 2023 | finance.yahoo.com

Biological Drug API Manufacturing Services market is projected to grow at a CAGR of 11.6% by 2033: Visiongain

December 11, 2023 | msn.com

What does the Chemist Warehouse merger with Sigma Healthcare mean for the pharmacy giant?

December 8, 2023 | bbc.com

Britishvolt bought by Australian firm Recharge Industries

November 28, 2023 | msn.com

Kronox Lab Sciences files draft papers with Sebi for IPO

November 8, 2023 | msn.com

Canada To Australia: New MDMA & Psilocybin Shipment On Its Way For Legal Therapeutic Market

November 7, 2023 | finance.yahoo.com

PharmAla Completes Historic First Shipment of MDMA and Psilocybin to Cortexa

November 2, 2023 | tmcnet.com

Pharmaceutical and Food Industries Drive Demand for Active and Intelligent Nano-Enabled Packaging Solutions

October 24, 2023 | tmcnet.com

Gluware Takes Center Stage at ONUG Fall 2023 in Keynote with World Wide Technology that Highlights the Power of Pre-Built Network Automation

September 27, 2023 | msn.com

South Waikato’s Cannasouth exports first shipment of cannabis API to Australia

August 24, 2023 | au.investing.com

The morning catch up: ASX to drop as September losses loom

August 24, 2023 | foxnews.com

Australia's wine industry grapples with oversupply issues amidst Chinese tariffs and pandemic disruptions

August 10, 2023 | fool.com.au

Wesfarmers share price climbs amid ACCC green light

July 31, 2023 | finance.yahoo.com

The Global Plant-based API Market size is expected to reach $42.6 billion by 2030, rising at a market growth of 5.8% CAGR during the forecast period

July 6, 2023 | afr.com

Why leaders with big egos worry Rob Scott the most

June 25, 2023 | reuters.com

UPDATE 1-Australia Wesfarmers' unit to acquire aesthetics firm SILK Laser in improved deal

See More Headlines

Receive API Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 4/17/2019
Today: 4/18/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Business Services
Industry: Medical Equipment Wholesale
Sub-Industry: N/A
Current Symbol: ASX:API
CUSIP: N/A
CIK: N/A
Web: www.api.net.au
Phone: +61-3-88553000
Fax: N/A
Employees: 2,020
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: 1.28
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 71.32
Current Ratio: 1.20
Quick Ratio: 0.77

Sales & Book Value

Annual Sales: $4.00 billion
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 8.26
Book Value: A$0.89 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 492,656,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Mr. Richard C. Vincent C.P.A.
B.Bus, (Accountancy), CPA, MD, CEO & Exec. Director
Mr. Peter Mendo
Chief Financial Officer
Mr. Dean Matthews
Chief Information Officer
Ms. Anne Mustow B.Com.
L.L.B., Gen. Counsel & Company Sec.
Mr. Stephen Arthurson
Gen. Mang. of People
Mr. D. Glance
NSW State Mang.

Key Competitors

View All Competitors

API Stock Analysis - Frequently Asked Questions

How were Australian Pharmaceutical Industries' earnings last quarter?: Australian Pharmaceutical Industries Limited (ASX:API) issued its earnings results on Wednesday, April, 17th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.05 by $0.00.
Is Australian Pharmaceutical Industries a good dividend stock?: Australian Pharmaceutical Industries (ASX:API) pays an annual dividend of A$0.04 per share and currently has a dividend yield of 2.29%. The dividend payout ratio is 1,333.33%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for API.
What other stocks do shareholders of Australian Pharmaceutical Industries own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Austal (ASB), Mod Resources (MOD), Harvey Norman (HVN), Evolution Mining (EVN) and Downer EDI (DOW).

This page (ASX:API) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial